G. Jackson

发表

Overexpression of EZH 2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

P. Workman, P. Clarke, Z. Walters, 2017 .

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

Caleb K. Stein, G. Morgan, P. L. Bergsagel, 2017, Blood Cancer Journal.

Oestrogen receptor α gene polymorphism associates with occurrence of graft-versus-host disease and reduced survival in HLA-matched sib-allo BMT

A. Dickinson, J. Cavet, J. Norden, 2003, Bone Marrow Transplantation.

Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation.

A. Dickinson, J. Cavet, P. Taylor, 2001, Blood.

Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation

J. Norden, J. Cavet, H. Cullup, 2002, Bone Marrow Transplantation.

Low incidence of myelodysplastic syndrome following transplantation using autologous non-cryopreserved bone marrow

S. Proctor, G. Jackson, P. Hamilton, 1997, Leukemia.

Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs

Y. Le Bihan, C. Wardell, N. Weinhold, 2021, Leukemia.

Position statement on the use of bortezomib in multiple myeloma

G. Morgan, J. Cavenagh, J. Cavenagh, 2008, International journal of laboratory hematology.

High Dose Ifosfamide in Combination with Etoposide and Epirubicin Followed by Autologous Stem Cell Transplantation in the Treatment of Relapsecd/Refractory Hodgkin's Disease: a Report on Toxicity and Efficacy On behalf of the Scotland and Newcastle Lymphoma Group

N. Russell, N. Russell, B. Angus, 2000, Leukemia & lymphoma.

The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study

S. Nagra, G. Cook, M. Gilleece, 2012, Bone Marrow Transplantation.

Constrictive pericarditis post allogeneic bone marrow transplant for Philadelphia-positive acute lymphoblastic leukaemia

A. Gascoigne, J. Cavet, S. Proctor, 2000, Bone Marrow Transplantation.

The use of an all oral chemotherapy (idarubicin and etoposide) in the treatment of acute myeloid leukaemia in the elderly: a report of toxicity and efficacy

N. Russell, A. Haynes, A. Iqbal, 1997, Leukemia.

Use of a skin explant model for predicting GVHD in HLA-matched bone marrow transplants – effect of GVHD prophylaxis

J. Starý, G. Jackson, A. Dickinson, 1999, Bone Marrow Transplantation.

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial

G. Morgan, W. Gregory, M. Drayson, 2016, Blood Cancer Journal.

Does zoledronic acid (ZOL) reduce skeletal-related events (SREs) and improve progression-free survival (PFS) in patients (Pts) with multiple myeloma (MM) with or without bone disease? MRC myeloma IX study results.

G. Cook, J. Byrne, F. Ross, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Are there benefits to long-term bisphosphonate treatment in multiple myeloma (MM)? Insights from temporal analyses of zoledronic acid (ZOL) versus clodronate (CLO) in the MRC Myeloma IX Trial.

G. Cook, J. Byrne, F. Ross, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue. The Newcastle and Northern Region Lymphoma Group.

G. Jackson, H. Lucraft, A. Lennard, 1993, British Journal of Cancer.

Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.

B. Angus, G. Jackson, R. Evans, 1994, British Journal of Cancer.